• TechCrunch
• CrunchBase
• More
  • TechCrunch Europe
  • TechCrunch France
  • TechCrunch Japan

Kevin Bitterman

edit

Kevin J. Bitterman, Ph.D. is a Principal at Polaris Venture Partners. Kevin joined Polaris in 2004 and focuses on investments in the life sciences. Prior to joining Polaris, Kevin completed his Ph.D. in genetics at Harvard Medical School. His doctoral research focused on small molecule regulation of the sirtuin class of protein deacetylases. Kevin has authored papers in the journals Nature, Science and Molecular Cell and is a co-founder of Genocea Biosciences, Parasol Therapeutics and Sirtris Pharmaceuticals. Kevin currently represents Polaris as a Director of Biolex Therapeutics, TARIS Inc., Follica Inc., Genocea Biosciences, Parasol Therapeutics and Solace Pharmaceuticals. Additionally, Kevin is a Board Observer to Pulmatrix Inc.

Recent Milestones

edit

• 
  Kevin Bitterman added a position as Principal at Polaris Partners. (1/1/04)
  Posted 12/16/09 at 4:05pm
• 
  Kevin Bitterman added a position as Ph.D at Polaris Venture Partners. (1/1/04)
  Posted 4/16/13 at 3:50am
• 
  Kevin Bitterman added a position as Director at Biolex Therapeutics.
  Posted 4/16/13 at 3:54am
• 
  Kevin Bitterman added a position as Director at Genocea Biosciences.
  Posted 4/16/13 at 3:54am
• 
  Kevin Bitterman added a position as Director at Follica.
  Posted 4/16/13 at 3:54am
• 
  Kevin Bitterman added a position as Director at Parasol Therapeutics.
  Posted 4/16/13 at 3:54am
• 
  Kevin Bitterman added a position as Co-founder at Sirtris Pharmaceuticals.
  Posted 4/16/13 at 3:50am
• 
  Kevin Bitterman added a position as Co-founder at Parasol Therapeutics.
  Posted 4/16/13 at 3:50am
• 
  Kevin Bitterman added a position as Co-founder at Genocea Biosciences.
  Posted 4/16/13 at 3:50am
• 
  Kevin Bitterman added a position as Director at Solace Therapeutics.
  Posted 4/16/13 at 3:54am
• 
  Kevin Bitterman added a position as Board Observer at Pulmatrix.
  Posted 4/16/13 at 3:54am
• 
  Kevin Bitterman added a position as Director at TARIS Biomedical.
  Posted 12/16/09 at 4:04pm

Videos

Sources